| Literature DB >> 33520600 |
María-Antonia Pastor-Nieto1,2, María-Elena Gatica-Ortega3.
Abstract
PURPOSE OF REVIEW: The main aims of fragrances are to create pleasing scents or to mask unpleasant odors. We hereby review their main exposure sources, presumed benefits, and unwanted effects, with special attention to allergic contact dermatitis (prevalence, regulatory environment, risk assessment methodology, and preventive measures). RECENTEntities:
Keywords: Allergic contact dermatitis; Cosmetics; Fragrance; Perfume; Risk assessment
Year: 2021 PMID: 33520600 PMCID: PMC7825391 DOI: 10.1007/s40521-020-00275-7
Source DB: PubMed Journal: Curr Treat Options Allergy
Fig. 1An 81-year-old non-atopic retired man who suffered from intensely pruritic long-lasting erythematous scaly lichenified involving the anterior and lateral aspects of his neck and abdomen. He applied eau de cologne as well as his wife’s scented moisturizer on the affected areas noting worsening. Patch tests were performed and relevant positive results obtained from FM, FM II, geraniol, geranium oil, citral, Rosa damascene extract, two personal colognes, and methylisothiazolinone and sodium metabisulfite. Relevance was attributed to fragrances which were declared in his own colognes and other personal care products. Lesions slowly resolved upon strict avoidance of the positive allergens.
Fig. 2Dermatitis involving the face, neckline, upper back, antecubital area, and hand interdigital spaces involving a non-atopic retired 69-year-old woman. Patch tests with the baseline, cosmetic, and fragrance series were performed, and positive results obtained from FM (3 +), FM II (3 +), geraniol (3 +), Evernia prunasti (3 +), hydroxycitronellal (3 +), and methylisothiazolinone and glucosides. We found geraniol in makeup remover wipes and hydroxicitronellal in several hair care products. She admitted to use fine perfumes containing the positive fragrance allergens.
Chemicals causing malodor [9••]
• Cyclic compounds (methyl pirrole, pyridine) • Aldehydes (octanal, nonanal) • Acidic compounds (isovaleric acid, hexenoic acid derivatives, acetic acid, thioglycolic acid) • 2-Pnethylfuran • Tyazoles • Thiols (methanethiol, 2-ethyl-1-hexanethiol) • Amines (butylamine, trimethylamine, triethylamine) • Sulfur compounds (dipropyl sulfide) • Skatole • Morpholines • Fatty acids • Fats • Proteins • Blood • Bacterial and fungal volatile organic compounds |
Screening markers of fragrance allergy in baseline patch test series
| Fragrance mix I (FM) | • Amyl cinnamal (α-amyl cinnamal) (1% in pet.) • Cinnamyl alcohol (cinnamic alcohol) (1% in pet.) • Cinnamal (cinnamic aldehyde) (1% in pet.) • Eugenol (1% in pet.) • Geraniol (1% in pet.) • Hydroxycitronellal (1% in pet.) • Isoeugenol (1% in pet.) • • Sorbitan sesquioleate (5% in pet.) as emulsifier. |
| Fragrance mix II (FM II) | • Citronellol (0.5% in pet.) • Citral (1% in pet.) • Coumarin (2.5 in pet.) • Hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) (2.5% in pet.) • Farnesol (2.5% in pet.) • α-Hexylcinnamal (5% in pet.) • Sorbitan sesquioleate (5% in pet.) as emulsifier • HICC is also tested separately at 5% [ |
| Other in the European baseline series | • • Colophonium (20% pet) • Propolis (10% pet) • Hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) (5% in pet.) • Linalool hydroperoxide (1% and 0.5% pet.) and limonene hydroperoxide (0.2% and 0.3%) (candidates proposed to be part of the European baseline series) |
Primary and secondary prevention. Possible strategies
• Regulations should be based on comprehensive risk assessments of unwanted effects on human health (not only contact dermatitis) and the environment in a more integrated approach [ • Fragrances should not be exempt from labeling, and labels should include all known fragrance ingredients and not be limited to 26 [ • The threshold for labeling should be related to the sensitizing potential. Since the 26 substances show heterogeneous sensitization properties, it is not scientifically justified to use a common threshold for all [ • Substances derived from fragrance auto-oxidation or metabolism inside the skin are more sensitizing than the parent compounds and should be contemplated [ • Restrictions concerning maximum concentrations in the finished product or fields of application should be considered [ • The classification of R43 (“may cause sensitization by skin contact”) should be applied to the 26 substances, and especially to strong allergens [ • The highest safety standards should be applied to children’s cosmetics. • Fragrances in topical medicines are unnecessary and should be avoided [ • Fragrances should be declared in absorbent hygiene products [ • Fragrance-free policy to protect the health of employees and clients in means of transportation (e.g., taxis) and other workplaces should be implemented [ • Strategies to help patients interpret the labeling (e.g., easier names, bigger fonts, warning pictograms) should be applied. Deciphering the INCI names and small fonts is troublesome for most patients requiring a big effort (training, infrastructure, time, education, and motivation) [ • • Misleading nomenclature (“ • Information regarding the risks of fragrances should be delivered to the non-sensitized population. Warning signals should be added to the containers [ • The authorities should control the compliance of the manufacturers with the regulations. This demands a high effort, as the number of cosmetics in the market is large, only random samples are assessed, and analytical determinations are expensive [ • Producers should respect regulations and recommendations by the SCCS and IFRA [ • Manufacturers should share information regarding the composition in the final products and provide physicians with samples of all fragrance chemicals whenever needed for the patch test investigations. |